Chelsea Therapeutics | Evaluate

August 07, 2014

Missed revenue and slow launches cloud Lundbeck outlook

Lundbeck gets Chelsea out of jail

February 19, 2014

Chelsea smiles as Northera gets not-so-accelerated approval

January 08, 2014

Small cap biotechs reap rewards of the bull market in 2013

January 03, 2014

Event – Optimism returns to Chelsea with dizzying speed

February 21, 2013

FDA’s short-term view helps Chelsea rise from the ashes

January 09, 2013

Sarepta joins the big league as best-performing 2012 share

December 06, 2012

Investors kick Chelsea after it trips on its Northera data again

October 10, 2012

Wockardt and Arena lead small-cap gainers through nine months

July 04, 2012

Obesity turnaround drives small cap gainers in H1

April 05, 2012

Vivus, Amylin and Threshold notable small cap gainers in Q1

Load More